All clinical trials on the European Union Clinical Trials Register (EUCTR) must report their results in the registry within a year of completion. This site tracks who's doing this and who isn't. Learn more »
These trials completed more than 12 months ago and should have reported results.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
|Status||Trial ID||Title||Completion date||Category|
|Ongoing||2006-005215-98||Treatment in patients with recurrent infections and IgG Subclass Deficiency, and/or Deficient Anti-Polysaccharide Antibody Response.||not-yet-due|
|Completed, but no date, and reported results||2009-009463-61||Controlled trail of immunoglobulin therapy for patients with idiopathic cardiomyopathy and endomyocardial parvovirus B19 persistence - - a prospective, double-blind, randomized, placebo-controlled cl...||bad-data|
|Ongoing||2009-017409-13||Dose escalating study to evaluate pharmacokinetics, efficacy and safety of apotransferrin in atransferrinemia patients Dosis eskalierende Studie zur Bewertung de Pharmakokinetik, Wirksamkeit und Si...||not-yet-due|
|Completed, but no date, and reported results||2012-005727-32||Pharmacokinetics and safety of the intravenous human immunoglobulin product Nanogam 100 mg/ml||bad-data|
|Completed, report not yet due Terminated||2014-001936-12||Efficacy and Safety of human apotransferrin in patients with β-thalassemia||2022-03-31||not-yet-due|